Debate of the Decade: RCTs in the Era of Precision Oncology
How do you design clinical trials in the era of precision oncology? Are prospective randomized controlled trials necessary anymore? Drs. Ray Kurzrock, Vivek Subbiah, and Christopher Booth join Dr. Chadi Nabhan to answer these important questions.
Hepatitis C and Sjögren’s Have Distinct Disease Profiles, Study Finds
Triplet Therapy Effective in TNBC: ATRACTIB Trial Results
Acute Hepatitis E in the Elderly: Global Trends, Health Inequities, and Future Projections